| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.21 | 4e-10 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-06 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |